Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993.Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration (FDA) and has been prescribed to several thousands of patients in the United States.As of 2014 the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Incyte is implementing good security practices.
Read more about the latest issues in cybersecurity
Domain hijacking is the act of changing the registration of a domain name without the permission of ...
The Domain Name System Security Extensions (DNSSEC or DNS Security Extensions) is a set of Internet ...
Compare Incyte's security performance with other companies